{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:07:33Z","timestamp":1789913253087,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1796,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/jid.2010.244","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T08:43:21Z","timestamp":1282207401000},"page":"133-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Evidence for a Pathophysiological Role of Keratinocyte-Derived Type III Interferon (IFN\u03bb) in Cutaneous Lupus Erythematosus"],"prefix":"10.1016","volume":"131","author":[{"given":"Sabine","family":"Zahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rehk\u00e4mper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate M.","family":"K\u00fcmmerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ferring-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"T\u00fcting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2010.244_bb0010","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An important role for type III interferon (IFN-lambda\/IL-28) in TLR-induced antiviral activity","volume":"180","author":"Ank","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/jid.2010.244_bb0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1191\/096120301678416042","article-title":"Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus","volume":"10","author":"Blomberg","year":"2001","journal-title":"Lupus"},{"key":"10.1038\/jid.2010.244_bb0020","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2004.033753","article-title":"Type I interferon correlates with serological and clinical manifestations of SLE","volume":"64","author":"Dall\u2019era","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/jid.2010.244_bb0025","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.21312","article-title":"Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes","volume":"44","author":"Doyle","year":"2006","journal-title":"Hepatology"},{"key":"10.1038\/jid.2010.244_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritic cells (natural interferon-alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions","volume":"159","author":"Farkas","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2010.244_bb0035","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1073\/pnas.0603082103","article-title":"Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus","volume":"103","author":"Gitlin","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2010.244_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2010.244_bb0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0961203308090019","article-title":"Pathogenesis of cutaneous lupus erythematosus","volume":"17","author":"Kuhn","year":"2008","journal-title":"Lupus"},{"key":"10.1038\/jid.2010.244_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.jid.5700530","article-title":"Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9","volume":"127","author":"Lebre","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.244_bb0055","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.21034","article-title":"Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus","volume":"52","author":"Meller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2010.244_bb0060","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2007111179","article-title":"CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease","volume":"19","author":"Menke","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/jid.2010.244_bb0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jbspin.2009.03.012","article-title":"Interferons and autoimmune disorders","volume":"76","author":"Meyer","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1038\/jid.2010.244_bb0070","doi-asserted-by":"crossref","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","article-title":"Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses","volume":"4","author":"Mordstein","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1038\/jid.2010.244_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/ar625","article-title":"Systemic lupus erythematosus and the type I interferon system","volume":"5","author":"Ronnblom","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/jid.2010.244_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"Ronnblom","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2010.244_bb0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0961203308090020","article-title":"The innate immune system in SLE: type I interferons and dendritic cells","volume":"17","author":"Ronnblom","year":"2008","journal-title":"Lupus"},{"key":"10.1038\/jid.2010.244_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2010.244_bb0095","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1038\/jid.2010.244_bb0100","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/jid.2009.42","article-title":"Lichenoid tissue reaction\/interface dermatitis: clinical and histological perspectives","volume":"129","author":"Sontheimer","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.244_bb0105","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.0022-202X.2005.23755.x","article-title":"Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine\/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus","volume":"124","author":"Wenzel","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.244_bb0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-0625.2007.00556.x","article-title":"Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches","volume":"16","author":"Wenzel","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2010.244_bb0115","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/jid.2008.96","article-title":"An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in \u201cinterface dermatitis\u201d","volume":"128","author":"Wenzel","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2010.244_bb0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"key":"10.1038\/jid.2010.244_bb0125","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.2007.08137.x","article-title":"The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets","volume":"157","author":"Wenzel","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2010.244_bb0130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun"},{"key":"10.1038\/jid.2010.244_bb0135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/intimm\/dxh093","article-title":"Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules","volume":"16","author":"Yoneyama","year":"2004","journal-title":"Int Immunol"},{"key":"10.1038\/jid.2010.244_bb0140","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J Virol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15349915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15349915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:49:26Z","timestamp":1743940166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15349915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0022202X15349915"],"URL":"https:\/\/doi.org\/10.1038\/jid.2010.244","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for a Pathophysiological Role of Keratinocyte-Derived Type III Interferon (IFN\u03bb) in Cutaneous Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2010.244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}